V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007472 | 190005895 | 1.74 | 69.3 | Palliative (P) | 2018-10-03 | 2018-10-18 | EW EuroEwing 2012 Arm B IE | N | N | EW EUROEWING 2012 ARM B IE | 101086787 |
| 190007480 | 190005896 | 0 | 50.4 | null | 2018-09-02 | 2018-09-23 | EW EuroEwing 2012 Arm B IE | 02 | null | TEMOZOLOMIDE | 101437620 |
| 190007488 | 190005897 | 1.51 | null | Palliative (P) | null | 2016-10-20 | Trial Unspecified | N | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101416184 |
| 190007490 | 190005898 | 1.74 | 78 | 03 | 2017-11-21 | 2017-12-19 | CISPLATIN + DOXORUBICIN + METHOTREXATE + MIFAMURTIDE | N | N | CARBOPLATIN + FLUOROURACIL | 101074391 |
| 190007492 | 190005899 | 0 | 37.4 | Palliative (P) | 2018-03-31 | 2018-03-31 | Carboplatin AUC 6 - 10 | N | Y | CARBOPLATIN | 100006620 |
| 190007499 | 190005900 | 1.5 | 43.6 | Curative (C) | 2018-12-07 | 2018-12-07 | GEMCARBO | 02 | N | ABEMACICLIB + FULVESTRANT | 101176230 |
| 190007503 | 190005901 | 1.73 | 53.6 | Neo-adjuvant (N) | null | 2019-04-19 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | FLUOROURACIL + IRINOTECAN | 101464057 |
| 190007517 | 190005902 | 1.74 | null | null | 2016-12-04 | 2016-12-15 | ETOPOSIDE | 02 | null | AVELUMAB | 100345861 |
| 190007521 | 190005903 | 1.83 | 48.8 | Curative (C) | null | 2021-05-05 | OST Rel Ifosfamide Etoposide | null | null | CAPECITABINE | 101655712 |
| 190007533 | 190005904 | 1.56 | 64 | Curative (C) | 2019-05-10 | 2019-05-14 | CAPECITABINE + TEMOZOLOMIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 101565691 |
| 190007546 | 190005905 | 1.71 | 57 | Palliative (P) | 2019-04-04 | 2019-04-04 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101183946 |
| 190007573 | 190005907 | 1.8 | 91.4 | 03 | 2017-07-07 | 2017-12-15 | EW EuroEwing 2012 Arm A VAI | 2 | Y | GEMCARBO | 100858964 |
| 190007576 | 190005908 | 1.75 | 59.2 | Curative (C) | 2021-07-29 | 2022-01-12 | Bevacizumab 7.5mg/kg | 02 | N | LANREOTIDE | 100302685 |
| 190007589 | 190005909 | 1.6 | 99.2 | Adjuvant (A) | 2018-05-05 | 2018-05-24 | DHAP | 01 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101819953 |
| 190007598 | 190005910 | 1.62 | 42.9 | Adjuvant (A) | 2018-04-02 | 2018-04-26 | Cisplatin + Gemcitabine (D 1 & 8) | 01 | null | OXALIPLATIN + MDG | 101687459 |
| 190007623 | 190005912 | 1.66 | 101.2 | null | 2018-02-26 | 2018-03-25 | Doxorubicin + Methotrexate | 02 | Y | PACLITAXEL | 100179928 |
| 190007632 | 190005913 | 1.78 | null | Curative (C) | null | 2016-05-25 | Carboplatin AUC 6 - 10 | N | N | CARBOPLATIN | 100557877 |
| 190007634 | 190005914 | 0 | 46.3 | Curative (C) | 2016-04-13 | 2016-04-30 | GemCarbo Days 1+8 | 02 | N | CAPECITABINE + OXALIPLATIN | 100639159 |
| 190007635 | 190005915 | 0 | 69 | null | 2016-02-07 | 2016-02-09 | NIVOLUMAB | 02 | null | LANREOTIDE | 100693012 |
| 190007642 | 190005916 | 1.85 | 12.5 | Curative (C) | 2017-01-06 | 2018-12-22 | CYCLOPHOSPHAMIDE | null | null | BEVACIZUMAB | 100590887 |
| 190007645 | 190005917 | 1.73 | 56.8 | Curative (C) | 2016-06-08 | 2016-09-03 | EURAMOS TRIAL | 02 | null | BLEOMYCIN + CISPLATIN + ETOPOSIDE + METHOTREXATE + VINCRISTINE | 100261474 |
| 190007649 | 190005918 | 1.56 | 50 | null | 2017-05-10 | 2017-05-11 | EURAMOS TRIAL | N | N | NIVOLUMAB | 100001004 |
| 190007654 | 190005919 | 1.67 | 63.1 | Adjuvant (A) | null | 2017-07-15 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100572959 |
| 190007655 | 190005920 | 1.66 | 93 | Palliative (P) | 2022-01-19 | 2022-02-09 | Irinotecan + Temozolomide | N | N | CISPLATIN + RT | 100132752 |
| 190007663 | 190005921 | 1.76 | 105.2 | Palliative (P) | 2018-04-20 | 2018-12-16 | OST Mifamurtide | null | Y | FLUOROURACIL + IRINOTECAN | 101728913 |
| 190007666 | 190005922 | 1.47 | 76 | null | 2017-04-05 | 2017-04-11 | LANREOTIDE | null | null | CAPECITABINE + TEMOZOLOMIDE | 100795617 |
| 190007671 | 190005923 | null | 55.75 | Palliative (P) | null | 2019-05-24 | Cyclophosphamide + Etoposide (iv) | 02 | N | CISPLATIN + GEMCITABINE | 100387549 |
| 190007678 | 190005924 | 1.79 | 59.2 | null | null | 2016-06-25 | IPILIMUMAB + NIVOLUMAB | 01 | N | CEMIPLIMAB | 101435177 |
| 190007680 | 190005925 | 1.77 | 78.9 | Adjuvant (A) | 2016-10-18 | 2016-10-18 | Doxorubicin + Methotrexate | 02 | N | CAPECITABINE | 100528330 |
| 190007686 | 190005926 | null | 71.65 | Palliative (P) | null | 2021-10-15 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 101026186 |
| 190007701 | 190005927 | 1.65 | 97.9 | Palliative (P) | null | 2016-10-13 | CAPECITABINE + TEMOZOLOMIDE | null | null | AVELUMAB | 100415934 |
| 190007716 | 190005928 | 0 | 38.4 | Palliative (P) | 2020-02-27 | 2020-02-28 | CISPLATIN + FLUOROURACIL | 01 | N | GEMCITABINE | 101506535 |
| 190007727 | 190005929 | 1.78 | 56.4 | Palliative (P) | null | 2019-01-08 | EURAMOS TRIAL | N | null | ETOPOSIDE | 101212824 |
| 190007749 | 190005930 | 1.8 | null | Curative (C) | null | 2021-02-11 | EW EuroEwing 2012 Arm A VAI | 02 | Y | STS NON-RHABDO EPSSG 2005 VINORELBINE | 100048445 |
| 190007755 | 190005931 | 1.79 | 50.5 | Palliative (P) | 2020-05-08 | 2020-05-11 | MAP | 02 | null | CARBOPLATIN + THIOTEPA + TOPOTECAN | 101408885 |
| 190007780 | 190005932 | 1.68 | 64 | null | null | 2018-05-06 | Oxaliplatin + Modified de Gramont | null | null | CISPLATIN + GEMCITABINE | 101755639 |
| 190007788 | 190005933 | 1.85 | 59.7 | Curative (C) | 2011-10-11 | 2021-12-07 | Cyclophosphamide + Topotecan | 02 | N | CETUXIMAB | 100589665 |
| 190007791 | 190005934 | 0 | 31 | Neo-adjuvant (N) | null | 2019-03-02 | Cyclophosphamide + Topotecan | 01 | N | CAPECITABINE + IRINOTECAN | 101649063 |
| 190007793 | 190005935 | null | 80.4 | Adjuvant (A) | 2019-06-02 | 2019-06-10 | null | 02 | N | GEMCITABINE | 101727107 |
| 190007798 | 190005936 | 1.7 | 78 | Adjuvant (A) | 2019-08-02 | 2019-08-16 | Cyclophosphamide + Topotecan | 02 | Y | NIVOLUMAB | 100064495 |
| 190007803 | 190005937 | 1.55 | 58 | Curative (C) | 2019-08-23 | 2020-01-08 | Bevacizumab 7.5mg/kg | 02 | N | GEMCARBO | 101777929 |
| 190007814 | 190005938 | null | 90 | null | null | 2019-04-27 | EW Rel rEECur Topotecan/Cyclophosphamide | 2 | Y | DOCETAXEL | 100097467 |
| 190007823 | 190005939 | 1.75 | 64.7 | Neo-adjuvant (N) | 2016-11-28 | 2016-12-04 | Carboplatin + Etoposide IV 3 day | 01 | N | METHOTREXATE | 101112359 |
| 190007826 | 190005940 | 1.62 | 74.45 | Palliative (P) | 2020-01-20 | 2020-02-07 | NB Rel CCLG guidelines Cyclo-Topotecan | 02 | N | GEMCITABINE | 100569318 |
| 190007827 | 190005941 | 1.83 | null | Curative (C) | 2020-12-16 | 2020-12-18 | Alectinib | 02 | N | EC | 101706184 |
| 190007835 | 190005942 | 1.51 | 81.5 | Palliative (P) | 2016-07-26 | 2017-02-22 | Epirubicin (weekly) | N | N | CARBOPLATIN + ETOPOSIDE | 100801007 |
| 190007845 | 190005943 | 1.77 | 116.2 | null | 2016-04-21 | 2016-10-02 | EW EuroEwing 2012 Arm B CE | 02 | N | DOXORUBICIN | 101845431 |
| 190007846 | 190005944 | 0 | 28 | null | 2013-11-29 | 2013-12-01 | Cisplatin+Gemcitabine (Days 1&8&15) | null | null | EOX | 100489791 |
| 190007852 | 190005945 | 1.68 | 78.9 | Curative (C) | 2017-07-05 | 2017-07-11 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101143537 |
| 190007855 | 190005946 | 1.72 | 42.3 | null | 2019-02-13 | 2019-05-09 | EW EuroEwing 2012 Arm B IE | N | Y | CETUXIMAB + RT | 100551244 |